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Of apples and oranges: Lessons learned
from the preparation of research protocols
for systematic reviews exploring the
effectiveness of Specialist Palliative Care
Jan Gaertner1*, Waldemar Siemens1, Barbara A. Daveson2, Melinda Smith2, Catherine J. Evans2,
Irene J. Higginson2 and Gerhild Becker1
Abstract
Background: Agreed terminology used in systematic reviews of the effectiveness of specialist palliative care ((S)PC))
is required to ensure consistency and usability and to help guide future similar reviews and the design of clinical
trials. During the preparation of protocols for two separate systematic reviews that aimed to assess the effectiveness
of SPC, two international research groups collaborated to ensure a high degree of methodological consensus and
clarity between reviews. During the collaboration, it became evident that close attention is needed to (i) avoid
ambiguity in the definition of advanced illness, (ii) capture the specialist expertise and prerequisites for SPC
interventions, and (iii) the multi-professional and multi-dimensional nature of PC. Also, (iv) the exclusion of
relevant studies or (v) impracticality of meta-analyses of the obtained data must be avoided.
The aim of this article is to present the core issues of the discussion to help future research groups to easily
identify potential pitfalls and methodologic necessities.
Core issue discussion: Core issues that arose from the discussion are presented along the research questions
according to the PICO process:
Population (P): Authors should refer to existing definitions of PC to ensure that, even if the review aims to
investigate specific patients (e.g. cancer patients), it is important to make clear that PC is applicable for all
life-limiting diseases and not limited to end-of-life or cancer.
Intervention (I): PC is a core responsibility of all disciplines (general PC). In contrast, SPC demands further
training and expertise. Therefore, core tenets of SPC interventions are that they are (i) multi-professional and
(ii) aim at the multi-dimensional nature of suffering.
Outcome (O): The main goal of PC is multi-dimensional (quality of life, suffering or distress). Yet, meta-analysis
may be complex to conduct due to the heterogeneity of the multi-dimensional outcomes. Therefore, the
assessment of uni-dimensional measures such as pain can also provide clinically relevant information that is
easier to obtain.
Discussion and conclusion: Recommendations for future systematic reviews and clinical trials include: (i)
Appraise the experience of other research groups who have produced similar systematic reviews or clinical trials.
(ii) Include studies that meet the multi-professional and multi-dimensional nature of PC and the specialization
requirements for SPC.
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(iii) Thoroughly weigh relevance and practicability of the primary outcome. Multi-dimensional tools such as quality-
of-life questionnaires assess the different dimensions of suffering (the true scope of PC), but uni-dimensional measures
such as pain are easier to assess in meta-analyses.
Keywords: Palliative care, Systematic review, Clinical trial, Specialist palliative care, Early palliative care
Background and aim of the article
As Specialist Palliative Care (SPC) services develop
internationally, there is a growing number of research
groups producing evidence-based recommendations or
guidelines for such services [1]. During the preparation
of protocols for a systematic review [2, 3] that aim to as-
sess the effectiveness of SPC, two separate research
groups exchanged and discussed their research protocols
to ensure consistency between the reviews and to
achieve a high degree of methodological consensus. It
became evident, that due to the substantial increase in
research activity in the field of PC, the heterogeneity of
the trial designs and the choice or absence of core defi-
nitions (e.g. for SPC as an intervention), it is crucial and
challenging to apply methodological standards that (i)
avoid ambiguity in the definition of advanced illness, (ii)
capture the specialist expertise and prerequisites for SPC
interventions and (iii), the multi-professional and
multi-dimensional nature of PC whilst avoiding (iv) the
exclusion of relevant studies or (v) impracticality of
meta-analyses of the obtained data.
Notably, three major areas of discussion were encoun-
tered when delineating the “PICO principle” (population-
intervention-comparison-outcome”) [4] for SPC research.
These concern the definitions for the included population
(P), interventions (I) and the primary outcome (O). In this
article, these key issues that arose from intensive discus-
sion between the two research groups are presented.
The aim of this article is to share the methodological
communication and decisions of two research groups.
Both groups have been working on systematic reviews
on specialist palliative inpatient or home care interven-
tions and consisted of PC researchers and clinicians.
Senior members of each group were involved in the dis-
cussion of national health-policy questions. The groups
discussed the most suitable definitions for the included
population (P), interventions (I) and the primary out-
come (O) for the preparation of systematic review proto-
cols that explore the body of evidence for effectiveness
of SPC.
We hope that our publication may facilitate the design of
future clinical trials and systematic reviews in the field of
palliative care (PC). For each core issue, the different ap-
proaches initially used by each research group are reported,
followed by the explanation of the consensus reached after
the discussion between both research groups.
Core issue discussion
P-population
Initial
Group I chose the following experience-based definition:
“Patients with an incurable stage of the disease (or a
combination of diseases) that is most likely to progress
and lead to the patients’ death despite all other
disease-modifying or life-prolonging interventions.”
Group II followed pre-existing definitions:
“Advanced Illness occurs when one or more conditions
become serious enough that general health and
functioning decline, and treatments begin to lose their
impact. This is a process that continues to the end of
life” [5]. Further, group two included patients with
“advanced (Coalition to Transform Advanced Care
(CTAC), 2013), life-limiting (Palliative Care Australia
2005), or life-threatening illness (NCP 2013), which
is likely to compromise their quality of life (The
WHOQOL Group 1995)” [2].
The group also provided the International Classifica-
tion of Diseases (ICD) 10 coding for all of the included
malignant and non-malignant heart-, lung-, neuro-
logical- vascular-, renal-, liver- and infectious diseases to
be as specific as possible (malignant: C00-C97; heart-
and vascular: I00-I52, I60-69; renal: N17, N18, N28, I12,
I13; liver: K70-K77; lung: J06-J18, J20-22; J40-47, J96;
neuro: F01, F03, G10, G12.2, G20, G23.1, G35, G90.3,
R54; infectious: B20-B24).
Consensus and future perspective
Refer to existing definitions Although the definition
proposed by group I more specifically focuses on the in-
evitability of the patient’s death, both groups agreed that
it was most useful and applicable to use the agreed inter-
national definition of advanced illness as proposed by
group II. Both groups noted that it is of importance, that
the patient population should not be restricted to pa-
tients near the end of life. Rather, SPC should be applic-
able early in the disease, depending on the patients’
needs. Nevertheless, future studies may both aim at
evaluating the effect of SPC early in the disease and on
end-of-life care [5].
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I-intervention
Initial
Group I decided to be as detailed as possible to ensure
the specialization and PC expertise of the SPC teams.
They modified the definition of SPC that was previously
used in the Cochrane review exploring effectiveness of
home PC services [6]:
Care primarily aiming at fostering of life and prevent
or reduce suffering was provided by:
either (i)
a) physicians (one or more) who have received higher
specialist training in PC, and
b) nursing staff (one or more nurses) who have
received higher specialist training, and
c) professionals (one or more) attached to the PC team
from a medical, psychological, social, theological or
other profession allied to health care who have
received further training in PC.
The presence of higher specialist education in PC will
be assumed adequate, if the authors would describe the
professionals as PC “specialists” or “experts” (e.g. “PC
physician”). Specialist education in “care of the dying”
(or described with synonyms) or specialist training com-
prising physical, psychosocial or spiritual core aspects of
PC will also be considered appropriate. We will also in-
clude an intervention as specialist PC if stated as such
by the authors.
or (ii)
a) health care professionals (e.g. nurses, physicians)
working at least 50 % of their time in PC, who have
not received higher specialist education but obtained
substantial clinical expertise over years and received
in-service training for their job, or
b) a uni-disciplinary team of health care professionals
(e.g. nurses) working at least 50 % of their time in
PC, in which one or more members may have
received some specialist training.
Group II chose a more general definition: “Inpatient
specialist palliative care varies between settings and
countries. In order to allow for these differences, inpatient
specialist palliative care will include care for patients
with an advanced, life-limiting or life-threatening illness
that is likely to compromise the patient’s quality of life in
some way with or without pre-bereavement care for un-
paid caregivers (provided while the patient is alive and
in hospital to either the unpaid caregiver alone or to-
gether with the patient) (Higginson 2003). The interven-
tion must be aiming to address the primary outcome of
this review and/or a secondary outcome. It must also be
delivered by a specialist palliative care team or by a
“specialist palliative care”, “palliative care” (but not a
generalist palliative care member, as defined in Shipman
2008) or “hospice” staff member.” [2].
Consensus and future perspective
Specialization, multi-professional- and multi-dimensional
care Both groups agreed that PC as a therapeutic ap-
proach (general or basic PC) is a core responsibility of
all disciplines. In contrast, SPC demands further training
and expertise. Both groups agreed that the definition of
group I may be too precise. This decision was based on
the experience of the research group with the previously
published Cochrane review about palliative home care
[6]. Here, it became evident that the great minority of
publications or corresponding authors are able to pro-
vide such specific information, as has been requested by
group I.
Both groups agreed that two core tenets of SPC inter-
ventions are that they (i) are multi-professional and (ii)
aim at the multi-dimensional nature of suffering. Thus,
interventions aiming for example solely at the physical
domain (e.g. pain management) or are reduced to a
physician visit may be part of PC but not PC itself.
Therefore, group I would keep multi-professionalism
and the multi-dimensional goal of care as key criteria to
recognize the intervention as SPC.
For future trials, we strongly advocate that researchers
should be as precise as possible in reporting the degree
of specialization of their SPC team and other informa-
tion as demanded in the detailed definition primarily
chosen by group I.
O-outcome
Initial
Group I: As the primary outcome, group I decided to as-
sess quality of life (QoL). The rationale for doing so was
that QoL is (i) the main goal of PC and (ii) multi-
dimensional by definition [7]. The latter is of importance
to distinguish PC from interventions aimed primarily at
single dimensions of QoL, such as pain control (physical
domain), depression (psychological domain), family in-
teractions (social domain) or spiritual well-being (spirit-
ual domain). We are aware of the diversity of assessment
tools and the difficulty associated with heterogeneity.
Yet, we believe that meta-analysis may be possible and
could add meaningful insights in some cases. If, in such
cases, different QoL measures were identified in the in-
cluded studies and a meta-analysis for continuous
outcomes would be meaningful, we suggest the use of
the standardized mean difference. However, absolute
changes on the original QoL scales should also be stated
(e.g., in the running text or in a separate table) to facili-
tate the interpretation of the findings. For such meta-
analyses, we prefer the use of both the random- and the
Gaertner et al. BMC Palliative Care  (2016) 15:43 Page 3 of 4
fixed-effects model, to take into account the heterogen-
eity of SPC interventions and small study effects [8].
Group II chose to examine pain intensity as the pri-
mary outcome. The rationale for doing so was that the
group recognized the diversity of QoL assessment tools
and the difficulty that is associated with heterogeneity
for meta-analysis.
Consensus and future perspective
Primary outcome: Multi-dimensional or pragmatic
Both groups agreed that the main goal of PC is multi-
dimensional by nature and definition, be it QoL, suffer-
ing or distress. Yet, meta-analysis may be complex to
conduct due to the heterogeneity of the tools assessing
these multi-dimensional outcomes. Therefore, the as-
sessment of uni-dimensional measures such as pain can
also provide clinically relevant information that is easier
to obtain.
Ideally, a consensus on the most valuable multi-
dimensional measures (e.g., PC needs, QoL and distress)
needs to be reached to reduce the heterogeneity of out-
come measures in future trials. This would extend the
evidence base of PC and facilitate meta-analysis [8].
Conclusion
The application of vague definitions would result in
methodologic shortcomings of systematic reviews and
therefore weaken evidence-based findings on the ef-
fects of SPC. We are aware that research groups
might also wish to adhere to their own, rather than
to standard (given) definitions. In this case, the
agreed upon definitions should be conveyed as precise
as possible.
The research groups suggest the following recommen-
dations for researchers developing protocols for system-
atic reviews or clinical trials in the field of PC:
(i) Critically appraise the experience of other research
groups in regards to the difficulties and key issues
encountered in the development of previous
systematic reviews or clinical trials. For this,
personal communication, careful reading of
limitation sections or studying published Cochrane
protocols will yield valuable information to identify
methodological pitfalls and learning points.
(ii) Close attention should be paid to whether the
research protocol correctly identifies studies that
meet the multi-professional, multi-dimensional
nature of PC and specialization requirements for
SPC. For this, careful observation of current
practice recommendations for example from PC
associations such as the European Association for
Palliative Care (EAPC) or the Center to Advance
Palliative Care (CAPC) is warranted.
(iii)Researchers should thoroughly weigh relevance and
practicability of the primary outcome. In our case,
QoL is complex and challenging to evaluate due to
its multi-dimensional nature and the diversity of the
available tools, while outcome measures such as
pain intensity are easier to assess but lack the
multi-dimensional aspects of PC.
(iv) In any case, the definitions for each PICO question
should be reported in detail in the protocol and the
resulting publication to ensure maximal transparency.
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